Curoverse
Agent22Agent Readiness: 22/100. Bottom 25%. Measured by StartupHub.ai. Median 41.Provides genomic and biomedical computing solutions for managing and analyzing large datasets.
About
Curoverse provides genomic and biomedical computing solutions that enable organizations to manage, process, analyze, and share massive biomedical datasets. Their core product, Arvados, is an open-source computing system designed for handling petabytes of data, serving bioinformaticians, researchers, IT teams, and clinical testing labs. Arvados offers flexible deployment options on-premise or in the cloud, ensuring data and software remain under user control for secure collaboration.
Key facts
At-a-glance profile data
- Website
- curoverse.com
- Headquarters
- Boston, United States
- Founded
- 2010
- Total funding
- $3M (Later Stage VC)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 24 Mar 2015 | Later Stage VC | $2M | - |
| 18 Feb 2014 | Seed Round | $2M | MassVentures |
Tech stack
Detected on curoverse.com, last scanned 10 Jul 2026. Run your own scan
- Frontend
- Bootstrap
- Analytics
- Google Analytics 4, Segment, Matomo
Frequently asked
How much funding has Curoverse raised?
Curoverse has raised a total of $3M in funding. The most recent round on record is Later Stage VC.
What is Curoverse's current status?
Curoverse's current operating status is: Inactive.